1.43
Lifeward Ltd stock is traded at $1.43, with a volume of 56,883.
It is up +0.00% in the last 24 hours and down -16.86% over the past month.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
See More
Previous Close:
$1.43
Open:
$1.45
24h Volume:
56,883
Relative Volume:
0.03
Market Cap:
$15.09M
Revenue:
$23.28M
Net Income/Loss:
$-23.75M
P/E Ratio:
-0.4689
EPS:
-3.05
Net Cash Flow:
$-25.22M
1W Performance:
+0.70%
1M Performance:
-16.86%
6M Performance:
-40.91%
1Y Performance:
-70.76%
Lifeward Ltd Stock (LFWD) Company Profile
Name
Lifeward Ltd
Sector
Industry
Phone
15082511154
Address
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LFWD
Lifeward Ltd
|
1.43 | 15.09M | 23.28M | -23.75M | -25.22M | -3.05 |
![]()
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-10-25 | Initiated | Laidlaw | Buy |
Apr-03-17 | Downgrade | Barclays | Equal Weight → Underweight |
Dec-16-16 | Initiated | Oppenheimer | Outperform |
Jul-15-16 | Initiated | Piper Jaffray | Overweight |
May-22-15 | Upgrade | Canaccord Genuity | Hold → Buy |
May-08-15 | Reiterated | Barclays | Equal Weight |
Oct-07-14 | Initiated | Barclays | Equal Weight |
View All
Lifeward Ltd Stock (LFWD) Latest News
Lifeward launches sales of ReWalk 7 personal exoskeleton in U.S. - MSN
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 - MSN
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients By Investing.com - Investing.com South Africa
Lifeward (LFWD) Launches ReWalk 7 Exoskeleton in the U.S., Shares Rise - GuruFocus
Lifeward (LFWD) Launches Next-Gen ReWalk 7 Personal Exoskeleton Nationwide | LFWD Stock News - GuruFocus
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients - Investing.com Australia
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market | LFWD Stock News - GuruFocus
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market - GlobeNewswire
Lifeward Launches Sales Of The ReWalk 7 Personal Exoskeleton In U.S. Market - Barchart.com
Lifeward Ltd. reports preliminary Q1 financial results - Investing.com Australia
Lifeward Ltd. reports preliminary Q1 financial results By Investing.com - Investing.com Canada
ReWalk Robotics stock hits 52-week low at $1.25 amid market challenges - Investing.com Australia
ReWalk Robotics stock hits 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Lifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton - TradingView
Lifeward gains FDA clearance for new ReWalk exoskeleton - Investing.com
Sector Update: Health Care Stocks Softer Thursday Afternoon -March 13, 2025 at 02:06 pm EDT - Marketscreener.com
Sector Update: Health Care -March 13, 2025 at 01:43 pm EDT - Marketscreener.com
What's Going On With Lifeward Shares Thursday?Lifeward (NASDAQ:LFWD) - Benzinga
FDA Approval of ReWalk7 Sends Lifeward (LFWD) Stock Climbing - Stocks Telegraph
Lifeward announces FDA clearance for ReWalk 7 exoskeleton - TipRanks
Lifeward Receives FDA Clearance for ReWalk 7 Exoskeleton; Shares Jump -March 13, 2025 at 09:41 am EDT - Marketscreener.com
Lifeward gains FDA clearance for new ReWalk exoskeleton By Investing.com - Investing.com UK
FDA Issues Clearance for ReWalk 7 Exoskeleton - GlobeNewswire
Revolutionary ReWalk 7 Exoskeleton Gets FDA Green Light, Medicare Coverage Ready - StockTitan
Lifeward stock holds Buy rating and $13 target from H.C. Wainwright - Investing.com Australia
Positive Outlook for Lifeward Driven by Strategic Partnerships and Market Expansion Initiatives - TipRanks
Lifeward stock holds Buy rating and $13 target from H.C. Wainwright By Investing.com - Investing.com South Africa
Lifeward reports operating loss of USD 15.2M in Q4 2024 - Medical Buyer
Rewalk Robotics Earnings Call: Growth Amid Challenges - TipRanks
Lifeward Ltd (LFWD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Lifeward Ltd. Reports Strong 2024 Revenue Growth - TipRanks
Lifeward: Q4 Earnings Snapshot - The Washington Post
Lifeward earnings missed by $0.19, revenue fell short of estimates - Investing.com South Africa
Lifeward Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Lifeward (LFWD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Lifeward Ltd Reports Q4 2024 Earnings: EPS of -$1.73 Misses Esti - GuruFocus.com
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Lifeward reports Q4 EPS ($1.73) vs (66c) last year - TipRanks
Lifeward Ltd. Reports Record Annual Revenue of $25.7 Million and Launches 2025 Sustainable Growth Plan - Nasdaq
Lifeward expects Q1 revenue to be the lowest of the year - TipRanks
Lifeward Ltd Stock (LFWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):